Friedman, C., Carvajal, R., Davar, D., Castanon, E., Ascierto, P., Calvo, E., O’Hara, M., Powell, S., Shapira-Frommer, R., Garralda, E., Renouf, D. J., Perets, R., Yunan, M., Ravindran, P., Hammell, A., O’Brien, S., Xu, K., Wilson, N., Jhatakia, A., … Gutierrez, M. (2022). 592 Phase 1/2a study of the novel nonfucosylated anti–CTLA-4 monoclonal antibody BMS-986218 ± nivolumab in advanced solid tumors: part 1 results. Regular and Young Investigator Award Abstracts, A620–A621. https://doi.org/10.1136/jitc-2022-sitc2022.0592
Subjects:
Cancer Immunotherapy
(OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy
(OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1136/jitc-2022-sitc2022.0592
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: